Public Health Surveillance, X-Linked Disorders, and Transfusion Reactions

Public Health Surveillance: Definitions and Goals

• Public Health Surveillance is defined as the ongoing, systematic collection, analysis, interpretation, and timely dissemination of health data to support public health action.
• The primary goals of surveillance include:
  • Early detection of outbreaks.
  • Monitoring disease trends over time.
  • Guiding public health interventions.
  • Facilitating the allocation of resources.
  • Evaluating the efficacy of health programs.
  • Informing policy decisions.

Core Functions of Surveillance

• Detect:
  • Identifying outbreaks quickly.
  • Recognizing unusual disease patterns.
• Monitor:
  • Tracking disease incidence and prevalence.
  • Measuring the burden of disease over time.
• Guide Action:
  • Directing control measures.
  • Supporting the allocation of resources.
• Evaluate:
  • Determining the effectiveness of interventions.
  • Informing future policy decisions.

Key Epidemiologic Measures

• Incidence:
  • Formula: $\text{Incidence} = \frac{\text{New Cases}}{\text{Population at Risk}}$
  • Function: Used to detect trends, identify outbreaks, and measure risk.
  • Critical Distinction: It measures new cases only.
• Prevalence:
  • Formula: $\text{Prevalence} = \frac{\text{Existing Cases}}{\text{Total Population}}$
  • Function: Used to determine the overall disease burden and for healthcare planning.
  • Critical Distinction: It measures all existing cases (both old and new).

Types of Surveillance Systems

• Passive Surveillance:
  • Description: Healthcare providers report cases routinely.
  • Strength: Low cost.
  • Limitation: Susceptible to underreporting.
• Active Surveillance:
  • Description: Public health agencies actively search for cases.
  • Strength: High sensitivity.
  • Limitation: Expensive to maintain.
• Sentinel Surveillance:
  • Description: Selected sites report data.
  • Strength: Good for monitoring trends.
  • Limitation: Does not provide full population coverage.
• Syndromic Surveillance:
  • Description: Uses symptom patterns, such as Emergency Department (ED) visits.
  • Strength: Provides the fastest early warning.
  • Limitation: Results are non-specific.

Laboratory Roles in Surveillance

• Confirming Cases:
  • Methods used include Culture, PCR, and Serology.
• Characterizing Pathogens:
  • Methods: Typing and Sequencing.
  • Purpose: Used to link clinical cases and track transmission pathways.
• Supporting Outbreak Investigations:
  • Providing prioritized testing and reference laboratory services.

Data Quality and Test Performance Concepts

• Data Quality Attributes:
  • Timeliness: Data must be available quickly.
  • Completeness: All required information must be included.
  • Accuracy: The data provided must be correct.
  • Representativeness: The data must reflect the true population.
• Sensitivity:
  • The ability to correctly identify individuals with the disease.
  • High sensitivity results in few false negatives.
• Specificity:
  • The ability to correctly identify healthy individuals.
  • High specificity results in few false positives.
• Positive Predictive Value (PPV) & Negative Predictive Value (NPV):
  • PPV: The probability that a positive result is truly positive.
  • NPV: The probability that a negative result is truly negative.
  • Prevalence Impact: PPV and NPV are dependent on disease prevalence. In areas of low prevalence, there are more false positives.

Public Health Escalation Thresholds

• Immediate notification is required if:
  • There is a sudden increase in incidence.
  • A disease cluster is identified.
  • A novel pathogen is detected.
  • There is a severe or unusual disease presentation.
  • A high-consequence pathogen is detected.
• Actions taken upon escalation:
  • Confirmatory testing.
  • Active case finding.
  • Molecular typing.

Basic Genetics and X-Linked Inheritance

• Sex Chromosomes:
  • Females = $XX$
  • Males = $XY$
• X-Linked Recessive Inheritance:
  • Key Feature: Males are usually affected because they possess only one X chromosome.
  • Female Carriers: Usually asymptomatic or only mildly affected.
  • Pedigree Clues: Multiple affected males, maternal inheritance pattern, and no male-to-male transmission.
• X-Linked Dominant Inheritance:
  • One pathogenic variant on the X chromosome causes the disease.
  • Affected Male: Passes the mutation to all daughters, but no sons.
  • Affected Female: Has a $50\%$ chance of transmitting the variant to each child.
• X-Inactivation (Lyonization):
  • Definition: The random inactivation of one X chromosome in females.
  • Result: Mosaicism.
  • Clinical Importance: Carrier females may exhibit symptoms if the normal X chromosome is preferentially inactivated.

Major X-Linked Disorders

• Hemophilia A:
  • Gene: $F8$
  • Deficiency: Factor VIII.
  • Findings: Prolonged bleeding, hemarthrosis (bleeding into joints), prolonged aPTT, and normal PT.
• Hemophilia B:
  • Gene: $F9$
  • Deficiency: Factor IX.
  • Findings: Similar clinical presentation to Hemophilia A.
• Duchenne Muscular Dystrophy (DMD):
  • Gene: $DMD$
  • Findings: Progressive muscle weakness, early childhood onset, primarily affecting boys.

Laboratory Evaluation of Bleeding Disorders

• Screening Test: aPTT (Activated Partial Thromboplastin Time).
  • Finding: Prolonged aPTT combined with a normal PT (Prothrombin Time) suggests Hemophilia A or Hemophilia B.
• Confirmatory Testing:
  • Hemophilia A: Factor VIII Assay.
  • Hemophilia B: Factor IX Assay.

Genetic Testing and Variant Classification

• Testing Options:
  • Single-Gene Sequencing: Used for known suspected disorders.
  • Multigene Panel: Used when several possible genes could be involved.
  • Whole Exome Sequencing: Used for complex cases.
• ACMG Variant Classification:
  • 1. Pathogenic.
  • 2. Likely Pathogenic.
  • 3. VUS (Variant of Uncertain Significance).
  • 4. Likely Benign.
  • 5. Benign.
• Clinical Note: A VUS should never be used alone for major clinical decisions.
• Recurrence Risks: If a mother is a carrier, there is a $50\%$ chance her sons will be affected and a $50\%$ chance her daughters will be carriers.
• Clinical Pearls: If a female presents with unexplained bleeding, consider factor assays and genetic testing. If a child has a positive result, test the mother to determine carrier status.

Transfusion Reactions: Hemolytic and Nonhemolytic

• Transfusion Reaction Definition: Any adverse event occurring during or after the transfusion of blood products.
• Acute Hemolytic Transfusion Reaction (AHTR):
  • Cause: ABO incompatibility.
  • Timing: Occurs within $24$ hours.
  • Signs: Fever, chills, flank pain, hemoglobinuria, and hypotension.
  • Severity: Can be fatal.
  • Workup: Includes DAT (Direct Antiglobulin Test), repeat crossmatch, CBC, bilirubin, LDH, and haptoglobin.
• Delayed Hemolytic Reaction:
  • Timing: Occurs days to weeks after transfusion.
  • Cause: Alloantibodies against minor antigens.
  • Findings: Falling hemoglobin, positive DAT, and mild hemolysis.
• Febrile Nonhemolytic Reaction:
  • Note: This is the most common transfusion reaction.
  • Cause: Cytokines or leukocyte antibodies.
  • Symptoms: Fever and chills.
  • Management: Must rule out hemolysis first.
• Allergic Reaction:
  • Symptoms: Urticaria (hives) and itching.
  • Severe Form: Anaphylaxis.
  • Treatment: Antihistamines; Epinephrine for anaphylaxis.

Pulmonary Transfusion Reactions: TRALI and TACO

• Transfusion-Related Acute Lung Injury (TRALI):
  • Timing: Occurs within $6$ hours.
  • Cause: Donor antibodies activate recipient neutrophils.
  • Findings: Acute respiratory distress and hypoxemia.
  • Treatment: Supportive care.
• Transfusion-Associated Circulatory Overload (TACO):
  • Cause: Volume/fluid overload.
  • Findings: Dyspnea (shortness of breath), hypertension (high blood pressure), and pulmonary edema.
  • Treatment: Diuretics.
• Differential Diagnosis (TRALI vs. TACO):
  • Cause: Immune reaction (TRALI) vs. Fluid overload (TACO).
  • Blood Pressure: Normal/Low in TRALI; High in TACO.
  • Pulmonary Edema: Present in both.
  • Diuretics: Do not help in TRALI; Help significantly in TACO.
  • Timing: $\le 6$ hours for TRALI; During or after transfusion for TACO.

Immediate Actions for Suspected Transfusion Reactions

1. STOP the transfusion immediately.
2. Maintain IV access.
3. Assess the patient.
4. Send the blood bag and a new patient sample back to the blood bank.
5. Perform a clerical check.
6. Order laboratory tests: DAT, CBC, and hemolysis studies.
7. Report the event according to institutional policy.

Hemovigilance

• Definition: The continuous monitoring and reporting of transfusion-related adverse events.
• Purposes:
  • Improve patient safety.
  • Identify trends.
  • Trace implicated donors.
  • Conduct lookback investigations.

High-Yield Exam Review

• Surveillance:
  • Most sensitive type: Active.
  • Cheapest type: Passive.
  • Earliest warning: Syndromic.
  • Incidence measures new cases; Prevalence measures existing cases.
• Genetics:
  • Lack of male-to-male transmission indicates X-linked inheritance.
  • Hemophilia A gene is $F8$.
  • Hemophilia B gene is $F9$.
  • Risk of carrier mother to sons: $50\%$ affected.
• Transfusion Reactions:
  • ABO incompatibility leads to Acute Hemolytic Reaction.
  • Most common reaction is Febrile Nonhemolytic.
  • Respiratory distress within $6$ hours suggests TRALI.
  • Fluid overload with hypertension suggests TACO.
  • The absolute first step in any reaction is to STOP the transfusion immediately.